8-Chloro-Adenosine in Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest safe dose of the drug
8-chloro-adenosine that can be given in the treatment of chronic lymphocytic leukemia (CLL).
Another goal is to learn how effective the drug is at treating leukemia.
Phase:
Phase 1
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
FDA Office of Orphan Products Development National Cancer Institute (NCI)